Kakeru Hisakane

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Interstitial Lung Disease

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Thoracic cancer

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Kaoruko Shimbu, Kakeru Hisakane, Naohiro Kadoma, Shunichi Nishima, Kenichiro Atsumi, Masahiro Seike, Takashi Hirose
Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series. OncoTargets and therapy 17 (2024)
Kakeru Hisakane, Takehiro Tozuka, Satoshi Takahashi, Namiko Taniuchi, Nobuhiko Nishijima, Kenichiro Atsumi, Tetsuya Okano, Masahiro Seike, Takashi Hirose
Platinum-combination chemotherapy with or without immune-checkpoint inhibitor in patients with postoperative recurrent non-small cell lung cancer previously treated with adjuvant platinum-doublet chemotherapy: A multicenter retrospective study. Thoracic cancer (2023)
Keiki Miyadera, Kakeru Hisakane, Yuki Kato, Kenichiro Atsumi, Hiroki Ono, Shu Tanaka, Kaoru Kubota, Masahiro Seike, Akihiko Gemma, Takashi Hirose
Black pleural effusion caused by a pancreaticopleural fistula associated with autoimmune pancreatitis: A case report. Medicine 101 (36) (2022)
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Akiko Yoshikawa, Kuniko Matsuda, Natsuki Takano, Satoshi Takahashi, Rintaro Noro, Akihiko Gemma
Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cells. Thoracic cancer 12 (11) (2021)